(Updated - December 9, 2022 5:09 AM EST)

Roth Capital analyst Jonathan Aschoff assumes coverage on MindMed (NASDAQ: MNMD) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE